The Role of Energy Homeostasis-Associated Gene Expression and Serum Adropin Levels in Patients with Familial Mediterranean Fever
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26052371 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Durkadin Demir Eksi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Faculty of Medicine, Alanya Alaaddin Keykubat University, Antalya 07425, Türkiye. Hauptthemen laut MEDLINE: Familial Mediterranean Fever, Energy Metabolism, Homeostasis. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alanya Alaaddin Keykubat Üniversitesi, Alanya Alaaddin Keykubat University Scientific Research Projects Unit.
Abstract (Originalsprache)
Familial Mediterranean Fever (FMF) is a genetic autoinflammatory disease primarily affecting populations in the Mediterranean region. The pathogenesis of FMF and the roles of various molecules remain unclear. Adropin, a protein encoded by the Energy Homeostasis-Associated Gene (ENHO), is involved in energy metabolism and inflammation. This study aimed to explore the relationship between ENHO expression, Adropin levels, and FMF, examining their correlations with disease characteristics. This study included 30 patients clinically diagnosed with FMF and 35 healthy controls. The ENHO expression in peripheral blood mononuclear cells was assessed using a qRT-PCR, and the serum Adropin levels were measured via ELISA. The ENHO expression was significantly elevated in the FMF patients compared to the controls (p = 0.0007), while no significant differences were observed in the serum Adropin levels between the groups (p = 0.81). A correlation analysis revealed a negative association between the ENHO expression and age (r = −0.47, p = 0.009), whereas the serum Adropin levels were positively correlated with age, disease onset, and diagnostic delay (p < 0.05). No significant associations were found between the ENHO expression and Adropin levels or FMF clinical features. These findings suggest that increased ENHO expression may play a role in FMF pathophysiology, potentially as a compensatory mechanism. The correlation between Adropin levels and disease onset indicates a potential protective role. Further studies are needed to confirm these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biology, Faculty of Medicine, Alanya Alaaddin Keykubat University, Antalya 07425, Türkiye.
- Department of Medical Biology, Tayfur Ata Sökmen Faculty of Medicine, Hatay Mustafa Kemal University, Hatay 31001, Türkiye.
- Department of Internal Medicine, Tayfur Ata Sökmen Faculty of Medicine, Hatay Mustafa Kemal University, Hatay 31001, Türkiye.
- Department of Internal Medicine, Faculty of Medicine, Siirt University, Siirt 56100, Türkiye.
ORCID-Profile: Durkadin Demir Eksi
Förderung
- Alanya Alaaddin Keykubat Üniversitesi
- Alanya Alaaddin Keykubat University Scientific Research Projects Unit
Zitieren
APA
Demir Eksi, D., Gulbol Duran, G., Celik, M. M., Eksi, Y. E., & Gunesacar, R. (2025). The Role of Energy Homeostasis-Associated Gene Expression and Serum Adropin Levels in Patients with Familial Mediterranean Fever. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26052371
Vancouver
Demir Eksi D, Gulbol Duran G, Celik MM, Eksi YE, Gunesacar R. The Role of Energy Homeostasis-Associated Gene Expression and Serum Adropin Levels in Patients with Familial Mediterranean Fever. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26052371
BibTeX
@article{DemirEksi2025,
author = {Demir Eksi, Durkadin and Gulbol Duran, Gulay and Celik, Muhammet Murat and Eksi, Yunus Emre and Gunesacar, Ramazan},
title = {The Role of Energy Homeostasis-Associated Gene Expression and Serum Adropin Levels in Patients with Familial Mediterranean Fever},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26052371}
}
EUVIMED